Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for STRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 16.58M
March 31, 2026 16.57M
December 31, 2025 8.584M
September 30, 2025 8.510M
June 30, 2025 8.472M
March 31, 2025 84.35M
December 31, 2024 8.253M
September 30, 2024 82.40M
June 30, 2024 81.86M
March 31, 2024 62.46M
December 31, 2023 61.01M
September 30, 2023 60.90M
June 30, 2023 60.47M
March 31, 2023 60.16M
December 31, 2022 57.50M
September 30, 2022 54.63M
June 30, 2022 48.67M
Date Value
March 31, 2022 46.93M
December 31, 2021 46.33M
September 30, 2021 46.26M
June 30, 2021 46.14M
March 31, 2021 46.10M
December 31, 2020 45.75M
September 30, 2020 38.09M
June 30, 2020 35.88M
March 31, 2020 23.23M
December 31, 2019 23.10M
September 30, 2019 23.09M
June 30, 2019 22.93M
March 31, 2019 22.93M
December 31, 2018 22.85M
September 30, 2018 22.85M
December 31, 2017 2.285M
September 30, 2017 22.85M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Upstream Bio, Inc. 54.77M
ACADIA Pharmaceuticals, Inc. 172.13M
Alnylam Pharmaceuticals, Inc. 133.73M
Anika Therapeutics, Inc. 13.38M
Savara, Inc. 205.40M